tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE

Gyre Therapeutics (GYRE) Technical Analysis

797 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Gyre Therapeutics’s (GYRE) Moving Averages Convergence Divergence (MACD) indicator is 0.88, suggesting Gyre Therapeutics is a Sell.
Gyre Therapeutics’s (GYRE) 20-Day exponential moving average is 13.12, while Gyre Therapeutics’s (GYRE) share price is $15.16, making it a Buy.
Gyre Therapeutics’s (GYRE) 50-Day exponential moving average is 13.01, while Gyre Therapeutics’s (GYRE) share price is $15.16, making it a Buy.

Gyre Therapeutics (GYRE) Pivot Points

Jul 22, 2024, 06:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.15
14.46
14.79
15.10
15.43
15.74
16.07
Fibonacci
14.46
14.70
14.85
15.10
15.34
15.49
15.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gyre Therapeutics (GYRE) Moving Averages

Jul 22, 2024, 06:10 AM
Period
Simple
Exponential
MA5
15.02Buy
14.80Buy
MA10
13.80Buy
14.04Buy
MA20
12.41Buy
13.12Buy
MA50
12.41Buy
13.01Buy
MA100
14.83Buy
13.76Buy
MA200
15.18Sell
13.26Buy
Gyre Therapeutics’s (GYRE) 10-Day exponential moving average is 14.04, while Gyre Therapeutics’s (GYRE) share price is $15.16, making it a Buy.
Gyre Therapeutics’s (GYRE) 100-Day exponential moving average is 13.76, while Gyre Therapeutics’s (GYRE) share price is $15.16, making it a Buy.
Gyre Therapeutics’s (GYRE) stock price is $15.16 and Gyre Therapeutics’s (GYRE) 50-day simple moving average is 12.41, creating a Buy signal.
Gyre Therapeutics’s (GYRE) stock price is $15.16 and Gyre Therapeutics’s (GYRE) 100-day simple moving average is 14.83, creating a Buy signal.
Gyre Therapeutics’s (GYRE) stock price is $15.16 and Gyre Therapeutics’s (GYRE) 200-day simple moving average is 15.18, creating a Sell signal.

Gyre Therapeutics (GYRE) Technical Indicators

Jul 22, 2024, 06:10 AM
Name
Value
Implied Action
RSI (14)
67.52
Neutral
STOCH (9,6)
79.86
Neutral
STOCHRSI (14)
85.00
Sell
MACD (12,26)
0.88
Sell
ADX (14)
28.81
Neutral
Williams %R
-18.49
Sell
CCI (14)
120.74
Sell
ATR (14)
1.07
-
Ultimate Oscillator
65.87
Neutral
ROC
27.07
Buy
Gyre Therapeutics’s (GYRE) Relative Strength Index (RSI) is 67.52, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Trend Strength Indicator (ADX) is 28.81, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Commodity Channel Index (CCI) is 120.74, creating a Sell signal.
Gyre Therapeutics’s (GYRE) Price Rate of Change (ROC) is 27.07, creating a Buy signal.

FAQ

Is GYRE a Buy, Hold, or Sell?
Based on GYRE’s technical indicators, GYRE is a Buy.
    What is GYRE’s RSI (14)?
    GYRE’s RSI (14) is 67.52, which suggests GYRE is a Neutral.
      What is GYRE’s MACD?
      GYRE’s MACD is 0.88, which suggests GYRE is a Sell.
        What is GYRE’s 5-day moving average?
        GYRE’s 5-day moving average is 15.02, which suggests GYRE is a Buy.
          What is GYRE’s 20-day moving average?
          GYRE 20-day moving average is 12.41, which suggests GYRE is a Buy.
            What is GYRE’s 50-day moving average?
            GYRE’s 50-day moving average is 12.41, which suggests GYRE is a Buy.
              What is GYRE’s 200-day moving average?
              GYRE’s 200-day moving average is 15.18, which suggests GYRE is a Sell.
                What is GYRE’s Williams % R (14)?
                GYRE’s Williams % R (14) is -18.49, which suggests GYRE is a Sell.
                  What is GYRE’s CCI (14)?
                  GYRE’s CCI (14) is 120.74, which suggests GYRE is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis